{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:21:22Z","timestamp":1787469682305,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11690-4","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:21:12Z","timestamp":1787408472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis and biological evaluation of quinazoline-carbazole derivatives as dual TXNIP\/DYRK1A inhibitors for the treatment of type 2 diabetes mellitus"],"prefix":"10.1007","author":[{"given":"Li","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"11690_CR1","unstructured":"Brussels Belgium (2021) International Diabetes Federation, IDF Diabetes Atlas, 10th edn, International Diabetes Federation"},{"issue":"6","key":"11690_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/db23-0553","volume":"73","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Yang J, Xia L, Wei T, Cui X, Wang D, Jin Z, Lin X, Li F, Yang K, Lang S, Liu Y, Hang J, Zhang Z, Hong T, Wei R (2024) Gut Microbiota-tryptophan metabolism-GLP-1 axis participates in \u03b2-cell regeneration induced by dapagliflozin. Diabetes 73(6):926\u2013940. https:\/\/doi.org\/10.2337\/db23-0553","journal-title":"Diabetes"},{"issue":"2","key":"11690_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"11690_CR4","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1021\/acs.jmedchem.0c02050","volume":"64","author":"K Kumar","year":"2021","unstructured":"Kumar K, Suebsuwong C, Wang P, Garcia-Ocana A, Stewart AF, DeVita RJ (2021) DYRK1A inhibitors as potential therapeutics for \u03b2-cell regeneration for diabetes. J Med Chem 64(6):2901\u20132922. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02050","journal-title":"J Med Chem"},{"key":"11690_CR5","doi-asserted-by":"publisher","unstructured":"Ding L, Zhang Y, Wang Y, Wang Y, Tong Z, Li P, Chen C, Wang B, Yue X, Li C, Wu Z, Liang X, Ma C, Gao L (2023) Zhx2 maintains islet \u03b2-cell mass and function by transcriptionally regulating Pax6. iScience 26(6):106871. https:\/\/doi.org\/10.1016\/j.isci.2023.106871","DOI":"10.1016\/j.isci.2023.106871"},{"issue":"9","key":"11690_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00018-018-2745-8","volume":"75","author":"AA Tinkov","year":"2018","unstructured":"Tinkov AA, Bj\u00f8rklund G, Skalny AV, Holmgren A, Skalnaya MG, Chirumbolo S, Aaseth J (2018) The role of the thioredoxin\/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? Cell Mol Life Sci 75(9):1567\u20131586. https:\/\/doi.org\/10.1007\/s00018-018-2745-8","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"11690_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11(2):136\u2013140. https:\/\/doi.org\/10.1038\/ni.1831","journal-title":"Nat Immunol"},{"key":"11690_CR8","doi-asserted-by":"publisher","unstructured":"Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M (2013) The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal. 19(11): 1266\u20131303. https:\/\/doi.org\/10.1089\/ars.2012.4757","DOI":"10.1089\/ars.2012.4757"},{"issue":"12","key":"11690_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/biom9120850","volume":"9","author":"S Ding","year":"2019","unstructured":"Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J (2019) Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules 9(12):850. https:\/\/doi.org\/10.3390\/biom9120850","journal-title":"Biomolecules"},{"issue":"7","key":"11690_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2174\/1389450123666220303092324","volume":"23","author":"R Basnet","year":"2022","unstructured":"Basnet R, Basnet TB, Basnet BB, Khadka S (2022) Overview on thioredoxin-interacting protein (TXNIP): a potential target for diabetes intervention. Curr Drug Targets 23(7):761\u2013767. https:\/\/doi.org\/10.2174\/1389450123666220303092324","journal-title":"Curr Drug Targets"},{"issue":"3","key":"11690_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2020.07.002","volume":"32","author":"LA Thielen","year":"2020","unstructured":"Thielen LA, Chen J, Jing G, Moukha-Chafiq O, Xu G, Jo S, Grayson TB, Lu B, Li P, Augelli-Szafran CE, Suto MJ, Kanke M, Sethupathy P, Kim JK, Shalev A (2020) Identification of an anti-diabetic, orally available small molecule that regulates TXNIP expression and glucagon action. Cell Metab 32(3):353\u2013365. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.002","journal-title":"Cell Metab"},{"key":"11690_CR12","doi-asserted-by":"publisher","unstructured":"Li A, Guan L, Su W, Zhao N, Song X, Wang J, Tang X, Li W, Jiao X (2023) TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives. J Enzyme Inhib Med Chem. 38(1): 2166937. https:\/\/doi.org\/10.1080\/14756366.2023.2166937","DOI":"10.1080\/14756366.2023.2166937"},{"issue":"7","key":"11690_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmet.2023.05.007","volume":"35","author":"G Basile","year":"2023","unstructured":"Basile G, Vetere A, Hu J, Ijaduola O, Zhang Y, Liu KC, Eltony AM, De Jesus DF, Fukuda K, Doherty G, Leech CA, Chepurny OG, Holz GG, Yun SH, Andersson O, Choudhary A, Wagner BK, Kulkarni RN (2023) Excess pancreatic elastase alters acinar-\u03b2 cell communication by impairing the mechano-signaling and the PAR2 pathways. Cell Metab 35(7):1242\u20131260. https:\/\/doi.org\/10.1016\/j.cmet.2023.05.007","journal-title":"Cell Metab"},{"issue":"5","key":"11690_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2337\/db22-0784","volume":"72","author":"T Wei","year":"2023","unstructured":"Wei T, Cui X, Jiang Y, Wang K, Wang D, Li F, Lin X, Gu L, Yang K, Yang J, Hong T, Wei R (2023) Glucagon acting at the GLP-1 receptor contributes to \u03b2-cell regeneration induced by glucagon receptor antagonism in diabetic mice. Diabetes 72(5):599\u2013610. https:\/\/doi.org\/10.2337\/db22-0784","journal-title":"Diabetes"},{"issue":"8","key":"11690_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00125-018-4639-6","volume":"61","author":"E Karakose","year":"2018","unstructured":"Karakose E, Ackeifi C, Wang P, Stewart AF (2018) Advances in drug discovery for human beta cell regeneration. Diabetologia 61(8):1693\u20131699. https:\/\/doi.org\/10.1007\/s00125-018-4639-6","journal-title":"Diabetologia"},{"key":"11690_CR16","doi-asserted-by":"publisher","unstructured":"Shirakawa J, Kulkarni RN (2016) Novel factors modulating human \u03b2-cell proliferation. Diabetes Obes Metab. 18 Suppl 1(Suppl 1):71\u201377. https:\/\/doi.org\/10.1111\/dom.12731","DOI":"10.1111\/dom.12731"},{"key":"11690_CR17","doi-asserted-by":"publisher","unstructured":"Vetere A, Choudhary A, Burns SM, Wagner BK Targeting the pancreatic \u03b2-cell to treat diabetes. Nat Rev Drug Discov 13(4):278\u2013289. https:\/\/doi.org\/10.1038\/nrd4231","DOI":"10.1038\/nrd4231"},{"key":"11690_CR18","doi-asserted-by":"publisher","first-page":"114062","DOI":"10.1016\/j.ejmech.2021.114062","volume":"229","author":"T Liu","year":"2022","unstructured":"Liu T, Wang Y, Wang J, Ren C, Chen H, Zhang J (2022) DYRK1A inhibitors for disease therapy: current status and perspectives. Eur J Med Chem 229:114062. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114062","journal-title":"Eur J Med Chem"},{"issue":"9","key":"11690_CR19","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.3390\/cells10092263","volume":"10","author":"A Barzowska","year":"2021","unstructured":"Barzowska A, Pucelik B, Pustelny K, Matsuda A, Martyniak A, St\u0119pniewski J, Maksymiuk A, Dawidowski M, Rothweiler U, Dulak J, Dubin G, Czarna A (2021) DYRK1A kinase inhibitors promote \u03b2-cell survival and insulin homeostasis. Cells 10(9):2263. https:\/\/doi.org\/10.3390\/cells10092263","journal-title":"Cells"},{"key":"11690_CR20","doi-asserted-by":"publisher","unstructured":"Kumar K, Wang PA, Swartz E, Khamrui S, Secor CB, Lazarus M, Sanchez RF Stewart A, DeVita RJ (2020) Structure-activity relationships and biological evaluation of 7-substituted harmine analogs for human \u03b2-cell proliferation. Molecules. 25(8) 1983. https:\/\/doi.org\/10.3390\/molecules25081983","DOI":"10.3390\/molecules25081983"},{"issue":"4","key":"11690_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nm.3820","volume":"21","author":"P Wang","year":"2015","unstructured":"Wang P, Alvarez-Perez JC, Felsenfeld DP, Liu H, Sivendran S, Bender A, Kumar A, Sanchez R, Scott DK, Garcia-Oca\u00f1a A, Stewart AF (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21(4):383\u2013388. https:\/\/doi.org\/10.1038\/nm.3820","journal-title":"Nat Med"},{"key":"11690_CR22","doi-asserted-by":"publisher","first-page":"107676","DOI":"10.1016\/j.bioorg.2024.107676","volume":"151","author":"L Guan","year":"2024","unstructured":"Guan L, Li A, Song P, Su W, Zhang S, Chen J, Jiao X, Li W (2024) Design, synthesis, and biological evaluation of \u03b2-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes. Bioorg Chem 151:107676. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107676","journal-title":"Bioorg Chem"},{"issue":"5","key":"11690_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrm2395","volume":"9","author":"T Riley","year":"2008","unstructured":"Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5):402\u2013412. https:\/\/doi.org\/10.1038\/nrm2395","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11690_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0076-6879(10)74005-2","volume":"474","author":"E Yoshihara","year":"2010","unstructured":"Yoshihara E, Chen Z, Matsuo Y, Masutani H, Yodoi J (2010) Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol 474:67\u201382. https:\/\/doi.org\/10.1016\/S0076-6879(10)74005-2","journal-title":"Methods Enzymol"},{"key":"11690_CR25","doi-asserted-by":"publisher","first-page":"153741","DOI":"10.1016\/j.phymed.2021.153741","volume":"93","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Aisker G, Dong H, Halemahebai G, Zhang Y, Tian L (2021) Urolithin A suppresses glucolipotoxicity-induced ER stress and TXNIP\/NLRP3\/IL-1\u03b2 inflammation signal in pancreatic \u03b2 cells by regulating AMPK and autophagy. Phytomedicine 93:153741. https:\/\/doi.org\/10.1016\/j.phymed.2021.153741","journal-title":"Phytomedicine"},{"key":"11690_CR26","doi-asserted-by":"publisher","first-page":"114857","DOI":"10.1016\/j.ejmech.2022.114857","volume":"244","author":"S Di Micco","year":"2022","unstructured":"Di Micco S, Rahimova R, Sala M, Scala MC, Vivenzio G, Musella S, Andrei G, Remans K, Mammri L, Snoeck R, Bifulco G, Di Matteo F, Vestuto V, Campiglia P, M\u00e1rquez JA, Fasano A (2022) Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2. Eur J Med Chem 244:114857. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114857","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11690-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11690-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:02:00Z","timestamp":1787468520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11690-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":26,"alternative-id":["11690"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11690-4","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}